Results 281 to 290 of about 99,561 (320)
Macrophage pyroptosis and its crucial role in ALI/ARDS. [PDF]
Front ImmunolCai Y +8 more
europepmc +1 more source
Predictive value of the monocyte count for determining the risk of postoperative moderate-to-severe ARDS in patients undergoing one-lung ventilation during radical treatment of esophageal cancer. [PDF]
Front Med (Lausanne)Zhang F +5 more
europepmc +1 more source
Learning from living: chance, curiosity and colleagues
Experimental Physiology, Volume 110, Issue 4, Page 525-528, 1 April 2025.
Hugh Montgomery
wiley +1 more source
Rare genetic variant risks in patients with sepsis-associated acute respiratory distress syndrome
Tosco-Herrera E +28 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Injury, 1994
The adult respiratory distress syndrome (ARDS) is a modem disease which has achieved prominence because of developments in intensive care medicine which have meant that severely ill patients can be supported for far longer than was previously possible. The first complete description of ARDS was made by Ashbaugh et al.
openaire +3 more sources
The adult respiratory distress syndrome (ARDS) is a modem disease which has achieved prominence because of developments in intensive care medicine which have meant that severely ill patients can be supported for far longer than was previously possible. The first complete description of ARDS was made by Ashbaugh et al.
openaire +3 more sources
New England Journal of Medicine, 2006
ARDS. 2,4 Mortality is overall improved with prolonged glucocorticoid treatment (91 of 276 patients; 33%; vs 111 of 242 patients; 46%; relative risk [RR], 0.76; 95% confidence interval [CI], 0.62 to 0.93; p 0.007), and the benefits are more significant when treatment is initiated before day 14 of ARDS (84 of 252 patients; 33%; vs 108 of 216 patients ...
Paul E. Marik +2 more
openaire +3 more sources
ARDS. 2,4 Mortality is overall improved with prolonged glucocorticoid treatment (91 of 276 patients; 33%; vs 111 of 242 patients; 46%; relative risk [RR], 0.76; 95% confidence interval [CI], 0.62 to 0.93; p 0.007), and the benefits are more significant when treatment is initiated before day 14 of ARDS (84 of 252 patients; 33%; vs 108 of 216 patients ...
Paul E. Marik +2 more
openaire +3 more sources
The Effect of ARDS on Survival: Do Patients Die From ARDS or With ARDS?
Journal of Intensive Care Medicine, 2017Objective: To investigate the contribution of acute respiratory distress syndrome (ARDS) in of itself to mortality among ventilated patients. Design and Setting: A longitudinal retrospective study of ventilated intensive care unit (ICU) patients. Patients: The analysis included patients ventilated for more than 48 hours.
Victor Novack +12 more
openaire +3 more sources
Chest, 2009
The heterogeneity of populations meeting criteria for ARDS may explain in part why no specific treatment has yet been shown to decrease mortality. To define the pathologic alterations associated with the syndrome, particularly the typical pattern of diffuse alveolar damage (DAD), and to evaluate whether etiologies or precipitating factors were missed ...
de Hemptinne, Quentin +4 more
openaire +3 more sources
The heterogeneity of populations meeting criteria for ARDS may explain in part why no specific treatment has yet been shown to decrease mortality. To define the pathologic alterations associated with the syndrome, particularly the typical pattern of diffuse alveolar damage (DAD), and to evaluate whether etiologies or precipitating factors were missed ...
de Hemptinne, Quentin +4 more
openaire +3 more sources
Critical Care Clinics, 2002
Improving the course and outcome of patients with ARDS presents a considerable challenge. An important component of meeting this challenge is a more comprehensive understanding of the heterogeneous pathophysiology of ARDS and the biologic response of the individual patient.
openaire +3 more sources
Improving the course and outcome of patients with ARDS presents a considerable challenge. An important component of meeting this challenge is a more comprehensive understanding of the heterogeneous pathophysiology of ARDS and the biologic response of the individual patient.
openaire +3 more sources